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Summary. The effects of prostaglandin E 1 (PGE 1) and hista- 
mine on activation of superoxide (O ~-) formation, exocytosis 
of fi-glucuronidase and aggregation i human neutrophils 
and HL-60 leukemic ells were studied. PGEb histamine 
and impromidine, a potent Hz-agonist, inhibited O2 
formation in neutrophils induced by the chemotac- 
tic peptide, N-formyl-L-methionyl-L-leucyl-L-phenylalanine 
(tMet-Leu-Phe) with ICso values of 0.5 gM, 8 ~tM and 2 gM, 
respectively. The full Hl-agonist and weak partial Hz- 
agonist, betahistine, was much less potent and effective 
than histamine. Dibutyryl cyclic AMP and forskolin mim- 
icked the effects of histamine and PGE1 on O~ formation. 
The Hz-antagonist, famotidine, competitively reversed 
histamine-induced inhibition of O2 formation with a pA2 
value of 7.5. Histamine inhibited O2 formation when added 
prior to or after fMet-Leu-Phe, fMet-Leu-Phe-induced ag- 
gregation and release of fl-glucuronidase in neutrophils were 
less sensitive to inhibition by PGE1, histamine, dibutyryl 
cyclic AMP and forskolin than O~- formation. The inhibitor 
of cyclic AMP-specific phosphodiesterase, rac-4-(3-butoxy- 
4-methoxybenzyl)-2-imidazolidinone (Ro 20-1724), ad- 
ditively enhanced the inhibitory effects of histamine and 
PGE1 on the above cell functions. In HL-60 cells differen- 
tiated by dimethyl sulfoxide or dibutyryl cyclic AMP, hista- 
mine, impromidine and PGE1 but not betahistine inhibited 
fMet-Leu-Phe-induced O~ formation as well. Our data 
suggest that histamine inhibits activation of neutrophils and 
HL-60 cells via Hz-receptors through activation of adenylyl 
cyclase and increased formation of cyclic AMP. As stimu- 
lated basophils and mast cells release high quantities of 
histamine, this intercellular signal molecule may play an 
inhibitory role in the activation of cytotoxic functions of 
myeloid cells. 
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Introduction 
Human neutrophils play an important role in the pathogen- 
esis of inflammatory processes and are activated by a variety 
of intercellular signal molecules uch as formyl peptides, 
platelet activating factor (PAF) and ATP (Malech and Gallin 
1987; Sandborg and Smolen 1988; Kuhns et al. 1988 ;Seifert 
et al. 1989c). Upon exposure to the formyl peptide, N- 
Send offprint requests to R. Seifert at the above address 
formyl-L-methionyl-L-leucyl-L-phenylalanine (fM t-Leu- 
Phe), neutrophils generate superoxide anions (02), the for- 
mation of which is catalyzed by NADPH oxidase (Rossi 
1986; Seifert et al. 1989a-c). PAF and ATP potentiate 
fMet-Leu-Phe-induced 02 formation (Dewald and Baggio- 
lini 1985; Kuhns et al. 1988; Ward et al. 1988; Seifert et al. 
1989c). In addition, fMet-Leu-Phe induces aggregation and 
exocytosis of fi-glucuronidase (Korchak et al. 1984; Seifert 
et al. 1989c). Receptors for formyl peptides, PAF and ATP 
couple to guanine nucleotide-binding proteins (G-proteins), 
stimulating phospholipase C with consequent activation of 
protein kinase C and calcium mobilization (Rossi 1986; 
Dubyak et al. 1988; Kuhns et al. 1988; Seifert et al. 1989a, 
b). Activation of aggregation and exocytosis may involve 
calcium-dependent processes and activation of protein 
kinase C (Sandborg and Smolen 1988). Of formation is 
activated by multiple mechanisms involving protein kinase 
C and direct activation by G-proteins (Rossi 1986; Seifert 
et al. 1986; Sandborg and Smolen 1988). 
Agents which increase the intracellular concentration f
cyclic AMP inhibit 02 formation and exocytosis. Among 
these agents is the intercellular signal molecule, prostaglan- 
din E1 (PGE1), which activates adenylyl cyclase in human 
neutrophils (Stolc 1977; Lad et al. 1985; Gryglewski et al. 
1987). In addition, the unspecific inhibitor of phosphodi- 
esterases (PDE), 3-isobutyl-l-methylxanthine (IBMX), and 
the specific inhibitor of cyclic AMP-specific PDE, rac-4- 
(3-butoxy-4-methoxybenzyl)-2-imidazolidone (Ro 20-1724) 
inhibit O~ formation (Lad et al. 1985; Weishaar 1987). 
Histamine is released from stimulated basophils and 
mast cells and plays an important role in the pathogenesis 
of inflammatory processes as well (Siraganian 1983; Owen 
1987). Histamine receptors are classified into H1-, H2- and 
H3-receptors according to the potency order of histamin- 
ergic agonists and antagonists (Ash and Schild 1966; Black 
et al. 1972; Durant et al. 1978; Arrang et al. 1983, 1987; 
Schwartz et al. 1986; Buschauer et al. 1989). Occupancy of 
HI- and H2-receptors by agonists leads to the activation of 
phospholipase C and adenylyl cyclase, respectively 
(Schwartz et al. 1986; Buschauer et al. 1989). 
There is a controversy concerning the role of histamine 
in the regulation of neutrophil functions. On one hand, 
particle-bound histamine induces O~- formation in alveolar 
macrophages via HI-receptors (Diaz et al. 1979). In ad- 
dition, histamine has been reported to induce the formation 
of thromboxanes in human neutrophils and to stimulate 
chemokinesis (Seligmann et al. 1983; Puustinen and Uotila 
1984). On the other hand, histamine has been reported to 
inhibit chemotaxis and fMet-Leu-Phe-induced O~ forma- 
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tion in human neutrophils (Seligmann et al. 1983). With 
respect to the release of/~-glucuronidase, histamine has been 
reported to inhibit exocytosis or to be without effect (Plaut 
and Lichtenstein 1982). In addition, histamine activates 
adenylyl cyclase in membranes of neutrophils and induces 
accumulation of cyclic AMP in these cells and in HL-60 
leukemic ells via Ha-receptors (Stolc 1977; Gespach and 
Abita 1982; Gespach et al. 1982). 
These controversial data prompted us to study in detail 
the role of histamine in the regulation of various neutrophil 
functions, i.e. O~ formation, exocytosis and aggregation i
comparison to PGE1. We here report hat histamine inhibits 
activation of neutrophils and HL-60 cells induced by various 
intercellular signal molecules. Our results suggest hat the 
effects of histamine involve Ha-receptors and an increase in 
the intracellular concentration f cyclic AMP. 
Materials and methods 
Materials. Impromidine was synthesized according to the 
method described by Durant et al. (1985). PAF (1-0-hexa- 
decyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) was a gift 
from Dr. S. Nigam (Abteilung fiir Gyn/ikologische Endo- 
krinologie, Universit/itsklinikum Steglitz, Freie Universi- 
t/it Berlin, FRG) and Ro 20-1724 was provided by Drs. 
U. Fischer and H. Gutmann (Hoffmann La-Roche, Ba- 
sel, Switzerland). Diphenyldramine, fMet-Leu-Phe, N-t- 
butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- 
leucyl-L-phenylalanine (Boc-PLPLP), cytochalasin B (CB), 
PGE1, superoxide dismutase, fcrricytochrome C, IBMX, 
famotidine, forskolin and p-nitrophenyl-]~-D-glucuronide 
were from Sigma Chemie (Taufkirchen, FRG). N~-methyl - 
2-pyridylethylamine (b tahistine) and cimetidine were from 
Aldrich Chemic (Steinheim, FRG). Dibutyryl cyclic AMP 
(dbcAMP) was from Pharma Waldhof (Diisseldorf, FRG). 
All cell culture media were from Biochrom (Berlin, FRG). 
Stock solutions of fMet-Leu-Phe (10raM), Boc-PLPLP 
(50 raM), cimetidine (100 raM) and CB (5 mg/ml) were pre- 
pared in dimethyl sulfoxide (MezSO) and were stored at - 
20°C. Forskolin (30mM), Ro20-1724 (10raM), PAF 
(10 raM) and PGE1 (2.5 raM) were dissolved in absolute 
ethanol and stored at -20  °C. Fresh stock solutions of hista- 
mine, betahistine and diphenhydramine (100 mM each in 
distilled water), famotidine and impromidine (10 mM in 
distilled water) were prepared aily. Sources of other ma- 
terials have been described elsewhere (Seifert et al. 1986, 
1989a-c;  Seifert and Schultz 1987; Seifert and Sch/ichtele 
1988). 
Isolation of neutrophils. Human neutrophils were isolated 
according to the procedure described by Markert et al. 
(1984) and Seifert et al. (1989b). Briefly, blood was obtained 
from healthy volunteers of either sex who had taken no 
drugs for at least three weeks. Neutrophils were isolated by 
dextran sedimentation and centrifugation through Ficoll- 
Hypaque. Cell preparations consisted of more than 98% 
viable neutrophils as judged by trypan blue dye exclusion 
and Pappenheim-stained smears. 
Cell culture. HL-60 cells were grown in suspension culture 
in RPMI-1640 medium supplemented with 10 % (by volume) 
horse serum, 1% (by volume) non-essential mino acids, 
2 mM L-glutamine, 50 U/ml penicillin and 50 #g/ml strepto- 
mycin in a humidified atmosphere with 7% CO2 at 37°C. 
To induce differentiation, HL-60 cells were seeded at a den- 
sity of 10 6 cells/ml and were cultured for 48 h with 0.2 mM 
dbcAMP or for 120 h with 160 mM MezSO (Chaplinski and 
Niedel 1982; Seifert and Schultz 1987; Seifert and Sch/ichtele 
1988). Pappenheim-stained smears howed that MeaSO- and 
dbcAMP-differentiated HL-60 cells consisted of more than 
98% myelocytes or cells beyond this stage. 
Assay for superoxide formation. 02 formation was monitor- 
ed by continuous measurement of ferricytochrome C re- 
duction inhibitable by superoxide dismutase, using an Uvi- 
kon 810 dual-beam spectrophotometer (Kontron, Eching, 
FRG) (Markert et al. 1984; Seifert et al. 1989b). Reaction 
mixtures (0.5 ml) contained 0.5-1.0 x 10 6 neutrophils or 
2.5 x 10  6 HL-60 cells, 100 gM ferricytochrome C and a 
buffer consisting of (mM) 138 NaC1, 6 KC1, 1 MgC12, 
1 CaC12, 1 NazHPO4, 5 NaHCO3, 5.5 glucose and 
20 Hepes/NaOH, pH 7.4. Reaction mixtures were preincu- 
bated for 5 min at 37 °C in the presence of the agents indi- 
cated. The absolute amounts of O~ generated were calcu- 
lated. 
Assay for release of fl-glucuronidase. Neutrophils (2.5 x 106 
ceils) were suspended in 500 gl of the buffer described above 
and were incubated for 5 rain at 37 °C in the presence of CB 
(5 ~tg/ml) and in the absence or presence of various agents. 
Reactions were initiated by the addition of fMet-Leu-Phe. 
After 10 min, reactions were terminated by placing the tubes 
onto melting ice. Reaction mixtures were centrifuged for 
10 rain at 250 x g at 4 °C. The determinations of/~-glucuroni- 
dase and lactate dehydrogenase activities of the supernatant 
fluids of the reaction mixtures were performed as described 
(Absolom 1986; Seifert et al. 1989c). The release of lactate 
dehydrogenase and/~-glucuronidase (in % of total cellular 
content) was calculated. 
Aggregation of neutrophils. Aggregation was measured by 
turbidometry (Korchak et al. 1984; Seifert et al. 1989c). 
Neutrophils (5 x 10 6 cells) were suspended in 900 gl of the 
buffer described above. Cells were incubated for 3 rain in the 
presence or absence of various agents prior to the addition of 
fMet-Leu-Phe. Aggregation experiments were carried out 
under constant stirring of cells at 103 rpm, using an Uvikon 
810 dual-beam spectrophotometer. Themaximum extent of 
aggregation was calculated. 
Results 
Superimposed kinetic registrations of 0~- formation in hu- 
man neutrophils are shown in Fig. 1. fMet-Leu-Phe at a 
maximally effective concentration (1 gM) reversibly acti- 
vated 02~formation which ceased after 6 min (trace 5). In 
contrast, histamine at a concentration of 1 mM did not 
activate 02 formation (trace 1). When added 5 min prior to 
or simultaneously with fMet-Leu-Phe, histamine inhibited 
02 formation (trace 2). In addition, histamine rapidly ter- 
minated 02 formation when added after fMet-Leu-Phe 
(traces 3 and 4). Similar results as with histamine were 
obtained with PGE1 (data not shown). A ten-fold excess o f  
the competitive antagonist of fMet-Leu-Phe, Boc-PLPLP 
(Jesaitis et al. 1986), completely prevented activation of 
Oy formation by the chemotactic peptide. In addition, Boc- 
PLPLP rapidly terminated fMet-Leu-Phe-induced 0~- for- 
mation (data not shown). 
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Fig. 1. Kinetics of O2 formation in human neutrophits. The effect 
of histamine on the kinetics of fMet-Leu-Phe-induced O£ formation 
was studied. Superimposed original registrations are shown. A, B, 
C and D indicate the addition of various agents at different imes. 
Trace 1: B, histamine (1 mM). Trace 2: B, fMet-Leu-Phe (1 i.tM); 
A or B, histamine (1 mM). Trace 3: B, fMet-Leu-Phe (1 gM); C, 
histamine (l raM). Trace 4: B, fMet-Leu-Phe (1 ~tM); D, histamine 
(1 mM). Trace 5. B, fMet-Leu-Phe (1 gM). Similar results were 
obtained in three experiments performed with neutrophils of differ- 
ent donors 
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Fig. 2A, B. Effect of histamine on concentration-response curves for 
fMet-Leu-Phe-induced O~- formation in human neutrophils. The 
effect of histamine (1 mM) on fMet-Leu-Phe-induced 02 formation 
was studied in the presence of CB (1 lag/ml) (Panel A) or in the 
absence of CB (Panel B). CB and histamine or solvent (control) 
were added to reaction mixtures 5min prior to fMet-Leu-Phe, fMet- 
Leu-Phe _+ CB ( I ) ;  fMet-Leu-Phe _+ CB plus histamine (O). Data 
shown represent he means of assay triplicates of an experiment 
carried out with neutrophils of one donor. Assay variation was less 
than 5%. Similar results were obtained in three experiments carried 
out with neutrophils of different donors 
The effect of histamine (1 mM) on O2 formation in 
neutrophils was studied in the presence of various concen- 
trations of fMet-Leu-Phe and in the absence or presence of 
CB (Fig. 2). In the absence of CB (panel B), fMet-Leu-Phe 
activated 02  formation with an ECso value of 45 nM and 
a maximum at 300 nM. In the absence of CB, histamine 
completely prevented activation of O2 formation induced 
by fMet-Leu-Phe at concentrations of up to 50 nM. The 
inhibitory effect of histamine on 02  formation induced by 
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Fig.3. Concentration-response curves to PGE1 and histaminergic 
agonists on fMet-Leu-Phe-induced Oy formation in human eutro- 
phils. The effects of PGE1 and histaminergic agonists were studied 
in the presence of fMet-Leu-Phe (1 gM) and CB (1 g/ml). PGE1 and 
histaminergic agonists or solvent (control) were added to reaction 
mixtures 5 min prior to fMet-Leu-Phe. PGE1 (0); histamine ( i ) ;  
impromidine (A); betahistine ( , ) .  In the absence of PGE1 and 
histaminergic agonists, fMet-Leu-Phe induced the formation of 30.8 
_+ 2.8 nmoles of O2/106 cells. Data shown are the mean of three 
experiments carried out with neutrophils of different donors which 
varied by less than 15% 
fMet-Leu-Phe at a maximally stimulatory concentration 
(1 gM) in the absence of CB amounted to 87%. CB 
potentiates 02  formation by increasing the number of for- 
myl peptide receptors on the plasma membrane (Jesaitis et 
al. 1986). In the presence of CB (panel A), fMet-Leu-Phe 
activated Of  formation with an ECs0 value of 25 nM, re- 
aching a maximum at a concentration of 100 nM. Histamine 
inhibited 02  formation without altering the ECs0 value and 
the maximally effective concentration for fMet-Leu-Phe- 
induced 02  formation. However, histamine completely in- 
hibited 02  formation induced by a very low concentration 
of fMet-Leu-Phe (10 nM) in the presence of CB. In the 
presence of CB, histamine inhibited 02  formation induced 
by fMet-Leu-Phe at a maximally stimulatory concentration 
by 73%. 
The concentration-response functions to PGE 1 and vari- 
ous histaminergic agonists on fMet-Leu-Phe-induced O2 
formation in neutrophils were compared (Fig. 3). PGE1 in- 
hibited fMet-Leu-Phe-induced 02  formation by more than 
70%. The effect of PGE1 was half-maximal at 0.5 ~tM and 
reached a plateau at a concentration of 3 pM. Histamine 
inhibited 02  formation with an ICso value of 8 gM and was 
maximally effective at 1 mM. Impromidine, a potent Ha- 
agonist (Durant et al. /978), inhibited 02  formation with 
an ICso value of 2 gM. The effect ofimpromidine was maxi- 
mal at a concentration of 30 ~tM. Impromidine and hista- 
mine were similarly effective as PGE1. Betahistine is a full 
agonist at H~-receptors and a weak partial agonist at H2- 
receptors in various peripheral tissues (Ganellin /982). In 
the brain, betahistine isa partial H 1- and H2-agonist (Arrang 
et al. 1985). This histaminergic agonist was much less potent 
and effective than histamine and impromidine to inhibit 
02  formation. 
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Fig.4A, B. Effect of the H2-antagonist, famotidine, on inhibition 
of fMet-Leu-Phe-induced O~ formation caused by histamine in 
human neutrophils. Panel A: The effect of famotidine at fixed con- 
centrations on inhibition of O2 formation caused by histamine was 
studied. CB (1 gg/ml) plus histamine and famotidine or solvent (con- 
trol) were simultaneously added to reaction mixtures. After a prein- 
cubation period of 5 min, O2 formation was initiated by the ad- 
dition of fMet-Leu-Phe (t gM). The concentrations of famotidine 
were as follows: 0 gM (O); 0.3 gM (A); 0.6 gM ( i ) ;  I gM (~'); 
5 laM ( t ) ;  10 gM ('~). Data shown are the means of assay tripli- 
cates of an experiment performed with neutrophils of one donor; 
these varied by less than 5%. Similar results were obtained in two 
experiments carried out with neutrophils of different donors. Panel 
B: Schild plot analysis of the data from Panel A. The agonist dose 
ratios A/A' were calculated, A being the concentration f histamine 
producing a given effect in the absence of famotidine and A' being 
the concentration fhistamine producing a given effect in the pres- 
ence of famotidine at a concentration B. The regression line was 
calculated and the pAz value (intercept of the graph with the ab- 
scissa) was calculated 
With respect o the postulated stimulatory effects of  H 1- 
agonists on phagocyte functions we addressed the question 
whether betahistine may stimulate neutrophils. Betahistine 
at a concentration of 10 gM did not enhance O2 formation 
induced by fMet-Leu-Phe at concentrations of 50 nM and 
1 gM. As betahistine is a partial H2-agonist, this component 
may blunt its stimulatory effect on Hi-receptors. Therefore, 
H2-receptors were blocked with the H2-antagonists, 
cimetidine or famotidine (Schunack 1987), at aconcen-  
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Fig.5A, B. Interaction of histamine and inhibitors of phosphodi- 
esterases on fMet-Leu-Phe-induced O~- generation in human 
neutrophils. The effects of Ro 20-1724 and IBMX were studied in 
the absence or presence of a submaximally inhibitory concentration 
of histamine (10 gM). Ro 20-1724, IBMX or solvent (control) were 
added to reaction mixtures 5min prior to fMet-Leu-Phe (I gM) in 
the absence or presence of histamine. Panel A: IBMX (11); IBMX 
plus histamine (O). Panel B: Ro 20-1724 ( i ) ;  Ro 20-1724 plus 
histamine (• ) .  In the absence of Ro 20-1724, IBMX and histamine, 
fMet-Leu-Phe plus CB (1 ~tg/ml) induced the formation of 28.8 _+ 
2.1 •moles of O2/106 cells. Data shown are the mean of three 
experiments performed with neutrophils of different donors which 
varied by less than 15% 
tration of 10 gM. Alternatively, H2-receptors were stimu- 
lated with impromidine at a concentration of 10 gM. How- 
ever, even under these conditions betahistine did not 
potentiate fMet-Leu-Phe-induced O j  formation. In ad- 
dition, betahistine itself at concentrations of I ~tM - 1 mM 
did not activate O2 formation in the presence or absence of 
CB (data not shown). Thus, we did not obtain any positive 
evidence for a stimulatory role of putative H 1-receptors on 
O2 formation in human neutrophils. 
The apparent affinity of famotidine for neutrophil H2- 
receptors was assessed by Schild plot analysis (Fig. 4) (Schild 
1947). Famotidine at concentrations ranging from 0 .3 -  
10 gM lead to parallel shifts of the concentration-response 
curves for histamine to the right. The transformation of 
these data into the Schild plot presentation was performed 
according to Tallarida and Jacob t1987). The equation for 
the regression line is y = -1 .03x  '+ 7.70 and the intercept 
with the abscissa (i.e. the pA2 value) is 7.5, These data 
indicate that famotidine is a competitive antagonist at 
neutrophil H2-receptors. In addition, the pAz value of 
famotidine in neutrophils i similar to the one of famotidine 
in other systems (Schunack 1987). In contrast to famotidine, 
the H 1-antagonist, diphenhydramine (Ganellin 1978; Nauta 
and Rekker 1978), did not reverse the inhibitory effect of 
histamine or betahistine on O~- formation (data not shown). 
The interactions of inhibitors of PDEs with histamine 
on O2 formation in human neutrophils were studied (Fig. 5). 
IBMX per se inhibited fMet-Leu-Phe-induced O2 formation 
by up to 60%, the effect of the methylxanthine being half- 
maximal at a concentration of 160 gM. The concentration- 
response curve for IBMX was, however, not sigmoid. This 
abnormality may be due to the fact that IBMX is also an 
antagonist at neutrophil adenosine A2-receptors (Schmei- 
chel and Thomas 1987). Blockade of A2-receptors by meth- 
Table 1. Inhibition by forskolin, dbcAMP, PGEI, 
Ro 20-1724 and combinations of these agents of 
induced Of formation in human eutrophils 
histamine and 
fMet-Leu-Phe- 
Addition 02 formation 
(in % of 
control) 
Forskolin (30 gM) 
dbcAMP (1 raM) 
Histamine (1 raM) 
PGE~ (10 p.M) 
Ro 20-•724 (1 laM) 
Histamine (1 raM) + Ro 20-•724 (1 gM) 
PGE~ (10 gM) + Ro 20-•724 (1 gM) 
Histamine (1 mM) + PGE1 (10 gM) 
Histamine (1 raM) + PGE1 (10 gM) 
+ Ro 20-1724 (1 gM) 
77 
35 
27 
20 
31 
10 
6 
17a 
6 b 
02 formation induced by fMet-Leu-Phe at a concentration f 1 gM 
was measured in the absence (control) or presence of various agents 
or combinations of agents. Experiments were carried out in the 
presence of CB (1 gg/ml). In the presence of CB and in the absence 
of inhibitors fMet-Leu-Phe induced the formation of 24.5 _+ 2.9 
nmoles of O2/106 cells. Agents or solvent were added to reaction 
mixtures 5 min prior to fMet-Leu-Phe. Data shown are the mean of 
four experiments carried out with neutrophils of different donors; 
these varied by less than 15%~ Statistical significance of the effects 
of combinations of histamine plus PGE1 was assessed using the 
Wilcoxon test. " Comparison of PGE1 versus PGE1 plus histamine, 
not significant; b comparison of PGE ~ plus Ro 20-1724 versus PGE 
plus Ro 20-1724 plus histamine, not significant 
ylxanthines causes potentiation of 02  formation (Schmei- 
chel and Thomas 1987). Thus, both inhibitory and stimula- 
tory components may contribute to the net effect of IBMX 
on 02  formation. In contrast to IBMX, the specific inhibitor 
of cyclic AMP-specific PDE, Ro 20-1724, inhibited Oy for- 
mation with a sigmoid concentration response function, its 
effect being half-maximal at 0.13 gM. IBMX plus histamine 
or Ro 20-1724 plus histamine additively inhibited 02  forma- 
tion. In addition, histamine shifted the midpoints of the 
inhibition curves for the PDE inhibitors to the left. 
The data obtained so far suggest that histamine inhibitis 
02  formation through an increase in cyclic AMP. Therefore, 
the effects of forskolin which directly activates adenylyl 
cyclase (Barovsky and Brooker 1985) and of the cell-per- 
meable analogue of cyclic AMP, dbcAMP, on O2 formation 
were studied (Table 1). Forskolin at a concentration of 
30 gM and dbcAMP at a concentration of I mM inhibited 
fMet-Leu-Phe-induced 02  formation by 23% and 65%, 
respectively. Table 1 also shows that the combination of 
histamine plus PGE~ at maximally effective concentrations 
did not accomplish complete inhibition of O2 formation, 
regardless of whether Ro 20-1724 was present or not. These 
data indicate that PGEI alone maximally activates adenylyl 
cyclase and that histamine, acting through a different recep- 
tor, cannot significantly increase the activity of adenylyl 
cyclase. 
The effects of histamine, PGE~ and Ro 20-1724 on 02  
formation induced by fMet-Leu-Phe, fMet-Leu-Phe plus 
PAF or fMet-Leu-Phe plus ATP were compared. PAF 
(1 gM) and ATP (100 gM) enhanced fMet-Leu-Phe-induced 
02  formation in the absence of CB by more than two-fold 
(Table 2). Histamine, PGE1 and Ro 20-1724 at maximally 
effective concentrations inhibited O~ formation induced by 
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Table 2. Inhibition by PGE1, histamine and Ro 20-1724 of 02 
formation induced by fMet-Leu-Phe, fMet-Leu-Phe plus PAF or 
fMet-Leu-Phe plus ATP in human neutrophils 
Stimulus fMet-Leu-Phe fMet-Leu-Phe fMet-Leu-Phe 
+ PAF + ATP 
Addition 02 generation (in % of control) 
Histamine (1 mM) 23 42" 31b 
PGE1 (10 gM) 6 27 a l0 b 
Ro 20-1724 (1 gM) 19 38" 22 b 
Histamine, PGE1, Ro 20-1724 or solvent (control) were added to 
reaction mixtures 5 rain prior to stimuli. Experiments were carried 
out in the absence of CB. The concentrations of stimuli were as 
follows: fMet-Leu-Phe, 1 gM; PAF, 1 gM; ATP, 100 ~M. In the 
absence of PAF or ATP, fMet-Leu-Phe induced the formation of 
2.2 _+ 0.4 nmoles of O2/10 6 cells, fMet-Leu-Phe plus PAF induced 
the formation of 7.1 _+ 1.2 nmoles of O2/106 cells and fMet-Leu- 
Phe plus ATP induced the formation of 4.3 + 0.3 nmoles of O2/ 
106 cells. The percentages shown in the Table are referred to these 
control values. Data shown are the mean of six experiments carried 
out with neutrophils of different donors; these varied by less than 
15%. The statistical significance of the differential sensitivity to 
inhibition of O~ formation by cyclic AMP-increasing agents was 
assessed using the Wilcoxon test. a Comparison of fMet-Leu-Phe 
versus fMet-Leu-Phe plus PAF, p < 0.05; b comparison of fMet- 
Leu-Phe versus fMet-Leu-Phe plus ATP, not significant 
fMet-Leu-Phe or fMet-Leu-Phe plus ATP to similar extents. 
These agents also inhibited Oy formation induced by fMet- 
Leu-Phe plus PAF, but this activation was significantly less 
sensitive to an inhibition by cyclic AMP-increasing agents 
than the former types of activation. Stimulus-dependent 
inhibition of O2 formation by cyclic AMP-increasing agents 
has also been noted in two recent studies (Gryglewski et al. 
1987; Seifert et al. 1989a). 
The effects of histamine, PGE1, Ro 20-1724, dbcAMP 
and forskolin and combinations of some of these agents on 
fMet-Leu-Phe-induced exocytosis of/~-glucuronidase and 
aggregation were studied. These experiments were perform- 
ed in order to answer the question whether histamine causes 
general inhibition of neutrophil activation. At a maximally 
stimulatory concentration, fMet-Leu-Phe induced the re- 
lease of 40% of the cellular content of/%glucuronidase 
(Table 3). Forskolin did not inhibit fMet-Leu-Phe-induced 
exocytosis. PGE1, histamine, Ro 20-1724 and dbcAMP in- 
hibited fMet-Leu-Phe-induced release of fl-glucuronidase by 
23%, 12%, 17% and 11%, respectively. PGE1 or histamine 
plus Ro 20-1724 additively inhibited the release of /% 
glucuronidase. Similarly to 02  formation, histamine did not 
significantly enhance inhibition of exocytosis caused by 
PGE1 at a maximally stimulatory concentration both in the 
absence and presence of Ro 20-/724. 
As was the case for fl-glucuronidase release, forskolin 
did not inhibit tMet-Leu-Phe-induced aggregation. PGE1, 
histamine and dbcAMP inhibited aggregation induced by 
fMet-Leu-Phe by 39%, 14% and 10%, respectively 
(Table 4). Ro 20-1724 at a subtreshold inhibitory concen- 
tration (10 nM) synergistically enhanced the inhibitory ef- 
fects of PGE~ and histamine. 
Finally, we studied the functional role of histamine in 
the regulation of 02  formation in differentiated HL-60 cells 
(Table 5). Upon exposure to fMet-Leu-Phe, dbcAMP-differ- 
entiated HL-60 cells generated higher amounts of 02  than 
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Table 3. Effect of forskolin, dbcAMP, PGEb histamine and Ro 20- 
1724 and combinations of these agents of fMet-Leu-Phe-induced 
release of/%glucuronidase in human neutrophils 
Addition fl-glucuronidase 
release (in % of 
control) 
Forskolin (30 gM) 98 
dbcAMP (1 raM) 89 
Histamine (1 mM) 88 
PGEt (10 pM) 77 
Ro 20-•724 (1 pM) 83 
Histamine (1 mM) + Ro 20-1724 (1 gM) 77 
PGE~ (10 pM) + Ro 20-1724 (1 p,M) 56 
Histamine (1 raM) + PGE~ (10 p,M) 70 a 
Histamine (1 mM) + PGE1 (10 p,M) 
+ Ro 20-•724 (1 gM) 52 b 
The release of/3-glucuronidase induced by fMet-Leu-Phe at a con- 
centration of I gM during an incubation time of 10 min was mea- 
sured in the absence (control) or presence of various agents or 
combinations ofagents. In the absence of stimulatory and inhibitory 
agents, the release of/3-glucuronidase and lactate dehydrogenase 
amounted to 5% of cellular content, none of the agents studied 
having an effect on the release of lactate dehydrogenase (data not 
shown). Forskolin, dbcAMP, Histamine, PGE1 and Ro 20-•724 
were added to reaction mixtures 5min prior to fMet-Leu-Phe. Data 
shown are the mean four experiments carried out with neutrophils 
of different donors; these varied by less than 15%. In the absence 
of inhibitors, fMet-Leu-Phe induced the release of 40 _+ 4% of the 
cellular content of//-glucuronidase. Statistical significance of the 
effects of combinations ofhistamine plus PGE~ was assessed using 
the Wilcoxon test. a Comparison of PGEI versus PGE~ plus hista- 
mine, not significant; b comparison of PGE ~ plus Ro 20-1724 versus 
PGE~ plus Ro 20-1724 plus histamine, not significant 
the Me2SO-differentiated ones, possibly due to the ex- 
pression of higher numbers of formyl peptide receptors in 
the former cells (Chaplinski and Niedel 1982). The effective- 
ness of  histaminergic agonists at a concentration of 100 pM 
to inhibit 02  formation in differentiated HL-60 cells was 
compared. Histamine and impromidine were similarly effec- 
tive inhibitors of Of  formation both in dbcAMP- and 
Me2SO-differentiated cells. In contrast, betahistine showed 
no substantial inhibitory effect. In comparison to histamine, 
PGE1 was a more effective inhibitor of  Of  formation in 
either cell type. In Me2SO-differentiated cells the effects of 
histaminergic agonists and PGE1 were less prominent han 
in the dbcAMP-differentiated ones. Thus, the induction of 
myeloid differentiation of HL-60 cells with dbcAMP does 
not impair the subsequent inhibition of  Of  formation by 
hormonal activators of adenylyl cyclase. These data indicate 
that the inhibition of Of  formation by cyclic AMP-increas- 
ing agents is independently regulated of cyclic AMP-induced 
differentiation. 
Discussion 
We show here that histamine inhibits Of  formation, ex- 
ocytosis and aggregation i human neutrophils and reduces 
Of  formation in differentiated HL-60 cells. Histaminergic 
agonists inhibit 02  formation in the potency order im- 
promidine > histamine >> betahistine. In addition, the ef- 
fects of histamine are competitively antagonized by the H2- 
Table 4. Effect of forskolin, dbcAMP, PGE1, histamine and Ro 20- 
1724 on fMet-Leu-Phe-induced aggregation fhuman neutrophils 
Addition Aggregation 
(in % of control) 
Forskolin (30 I-tM) 100 
dbcAMP (1 mM) 90 
Histamine (1 mM) 86 
PGE~ (10 gM) 61 
Ro 20-1724 (10 nM) 99 
Histamine (1 mM) + Ro 20-1724 (10 nM) 71 
PGE1 (10 l-tM) + Ro 20-1724 (10 nM) 42 
To stirred suspensions of neutrophils various agents or soivent 
(control) were added 3 min prior to the addition of fMet-Leu-Phe 
(1 ~tM). The extent of aggregation is referred to that induced by 
fMet-Leu-Phe (i pM). Data shown represent the mean of three 
experiments carried out with neutrophils of different donors; these 
varied by less than 15% 
Table 5. Inhibition by histamine, impromidine, betahistine and 
PGE1 of fMet-Leu-Phe-induced superoxide formation in differen- 
tiated HL-60 cells 
Differentiation-inducing agent dbcAMP Me2SO 
Addition O£ generation 
(in % of control) 
Histamine (100 IxM) 50 70 
Impromidine (100 pM) 58 80 
Betahistine (100 gM) 95 102 
PGE1 (10 gM) 29 46 
To induce differentiation, HL-60 cells were cultured for 48 h with 
0.2 mM dibutyryl cyclic AMP (dbcAMP) or for 120 h with 160 mM 
dimethyl sulfoxide (MezSO). Thereafter, cells were harvested and 
were suspended in the buffer for determination f O~ formation 
not supplemented with the differentiation-inducing agents. CB 
(1 gg/ml) plus histamine, impromidine, betahistine, PGE1 or solvent 
(control) were added to reaction mixtures 5min prior to fMet-Leu- 
Phe (1 gM). In dbcAMP- and Me2SO-differentiated HL-60 cells, 
fMet-Leu-Phe induced the formation of 19.2 _+ 4.6 and 12.1 _+ 
2.6 nmoles of O2/106 cells, respectively. The percentages shown in 
the Table are referred to these control values. Data shown represent 
the mean of four experiments carried out with different preparations 
of HL-60 cells; these varied by less than 10% 
antagonist, famotidine, but not by the Hi-antagonist,  di- 
phenhydramine. In agreement with our present results con- 
cerning histaminergic nhibition of O2 formation, Gespach 
and Abita (1982) and Gespach et al. (1982) reported on a 
similar potency order of histaminergic agonists to stimulate 
the accumulation of cyclic AMP in human neutrophils and 
in HL-60 cells. Histamine and PGE1 are similarly effective 
inhibitors of the activation of myeloid cell functions. The 
effects of  histamine and PGE a on the accumulation of cyclic 
AMP (Gespach and Abita 1982; Gespach et al. 1982; Lad 
et al. 1985) and on inhibition of neutrophil function are 
additively enhanced by inhibitors of PDEs, such as IBMX 
and Ro 20-1724, suggesting that both intercellular signal 
molecules act by a mechanism they have in common. We 
conclude that histamine inhibits various myeloid functions 
via H2-receptors through activation of adenylyl cyclase and 
increased formation of cyclic AMP. 
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fMet-Leu-Phe induces a transient activation of O~ for- 
mation which is rapid in onset. As PGEI and histamine 
rapidly inhibit O~ formation, the functional response to 
these agents apparently does not require sustained accumu- 
lation of cyclic AMP. Lad et al. (1985) have shown that 
small increments in the intracellular concentration of cyclic 
AMP induced by PGE1 are sufficient o inhibit 02 forma- 
tion. Thus, activation of O~- formation by fMet-Leu-Phe is 
an inhibitable process which is rapidly terminated by ad- 
dition of competitive antagonists, e.g. Boc-PLPLP, or by 
addition of hormonal activators of adenylyl cyclase, e.g. 
histamine and PGE1. 
Histamine does not alter the ECs0 value and the 
maximally stimulatory concentration of fMet-Leu-Phe-in- 
duced O2 formation in neutrophils in the presence of CB, 
suggesting that histamine does not mediate its effects via 
modification of the number and/or affinity state of formyl 
peptide receptors. The differential sensitivity of various 
classes of stimulatory agonists to an inhibition by histamine 
suggests that these stimulatory signal molecules activate dif- 
ferent signal transduction pathways which are differently 
modulated by an increase of cyclic AMP. In addition, acti- 
vation of O~- formation is more sensitive to inhibition by 
histamine and PGEt than aggregation and exocytosis. Fur- 
thermore, forskolin and dbcAMP mimick the differential 
inhibition profiles induced by histamine and PGE~. Thus, it 
is not likely that this differential sensitivity is due to the 
parallel activation of stimulatory H~-receptors and inhibi- 
tory Hz-receptors. A greater sensitivity of O~- formation 
than of exocytosis to inhibition by prostaglandins has re- 
cently been noted by Lad et al. (1985). All these data also 
suggest that differential sensitivity of G-proteins to a cyclic 
AMP-mediated inhibition of their function is not involved 
in this phenomenon as dbcAMP and forskolin act at sites 
distal from G-proteins. Possibly, protein kinase A-catalyzed 
phosphorylation reactions differently affect the functional 
state of proteins involved in the regulation of various effector 
systems, finally leading to activation of 02 formation, ex- 
ocytosis and aggregation. 
There is recent evidence that platelet products modulate 
O2 formation in human eutrophils. Platelets ynergistically 
enhance and inhibit O2 formation via the release of ATP 
and prostaglandins, respectively (Ward et al. 1988; Metha 
et al. 1988). In addition, PAF which is secreted from 
neutrophils, basophils and mast cells potentiates fMet-Leu- 
Phe-induced O~- formation (Siraganian 1983; Dewald and 
Baggiolini 1985; Seifert et al. 1989c). We show here that 
histamine, PGE1 and Ro 20-1724 inhibit O2 formation in- 
duced by fMet-Leu-Phe, fMet-Leu-Phe plus PAF or fMet- 
Leu-Phe plus ATP. Basophils and mast cells release high 
quantities of histamine upon stimulation with various inter- 
cellular signal molecules uch as IgE, complement C5a and 
fMet-Leu-Phe (Siraganian 1983; Warner et al. 1987). These 
findings suggest that basophils via the release of histamine 
may play an inhibitory role in the formyl-peptide-, PAF- 
and ATP-induced activation of O2 formation. These results 
support he concept hat various types of blood cells com- 
municate via the release of intercellular signal molecules 
to regulate cytotoxic functions of neutrophils. In addition, 
histamine may play a negative feed-back role in the regu- 
lation of cytotoxic functions of basophils and mast cells 
themselves, as these cells generate O~- as well (Henderson 
and Kaliner 1978; Kitagawa et al. 1980). 
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